Found 6 matching trials
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC PHASE3 This is a prospective, randomized, placebo-controlled, double-blind, multic...
Show More Status
Active Not Recruiting
Location
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command
Learn More & Join Trial
Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma PHASE1 This study will evaluate efficacy and safety of Toripalimab Injection (JS00...
Show More Location
Fudan University Zhongshan Hospital
Learn More & Join Trial
Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06) PHASE2 This study will evaluate the efficacy and safety of Oncolytic virus H101 co...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma PHASE2 The investigators design a phase IIB clinical study to explore the efficacy...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Learn More & Join Trial
A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) PHASE2 This is an open-label, single-arm, national multicenter phase II clinical s...
Show More Location
Beijing Cancer hospital
Learn More & Join Trial
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers PHASE2 The investigators design a phase II clinical study to explore the efficacy ...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Learn More & Join Trial